← Leaderboards
Ralf Landgraf
University Of California Los Angeles
$4,127,423
Attributed
$5,334,981
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $632.2K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,334,981 · 4
By mechanism
R01$4,943,086 · 2
S10$350,959 · 1
F32$40,936 · 1
Top collaborators
- Francisco Vega-Vazquez5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- David T Wong$54,826,713
- Mary Ann Woo$5,031,750
- Guy Soo Hoo$344,349
- David S Chia$9,399,833
- Fang Wei$3,486,544
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LinePhosphorylationProteinsTherapeutic UsesCellsReceptorModificationSignal TransductionMediatingScaffoldTherapeutic TargetResponseInsightProteomicsPhenotypeDrug ResistanceAntineoplastic AgentsEquilibriumBaseLigandsOverexpressionInhibitor/AntagonistAptamerProperty
Grant awards (19)
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance$470,533
R01 · FY2023 · CA · contact PI
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance$470,533
R01 · FY2022 · CA · contact PI
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance$490,064
R01 · FY2021 · CA · contact PI
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance$490,953
R01 · FY2020 · CA · contact PI
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance$493,034
R01 · FY2019 · CA · contact PI
A Biacore T200 for Molecular Interaction Studies at the University of Miami$350,959
S10 · FY2012 · OD · contact PI
Rewiring ERBB Signaling in Cancer Cells$241,727
R01 · FY2012 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$27,540
R01 · FY2012 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$11,934
R01 · FY2012 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$241,727
R01 · FY2011 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$47,678
R01 · FY2010 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$273,042
R01 · FY2009 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$273,042
R01 · FY2008 · CA · contact PI
Rewiring ERBB Signaling in Cancer Cells$273,042
R01 · FY2007 · CA · contact PI
Role and Mechanism of HER2 Self-Association in Cancer$268,547
R01 · FY2006 · CA · contact PI
Role and Mechanism of HER2 Self-Association in Cancer$275,010
R01 · FY2005 · CA
Role and Mechanism of HER2 Self-Association in Cancer$273,230
R01 · FY2004 · CA
Role and Mechanism of HER2 Self-Association in Cancer$321,450
R01 · FY2003 · CA
UNDERSTANDING AND REDEFNING NEUREGULIN SPECIFICITY$40,936
F32 · FY2000 · AI